Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-021947
Filing Date
2021-02-12
Accepted
2021-02-12 16:17:58
Documents
1
Group Members
JEROME G. PFUNDMICHAEL L. SJOSTROMSECTORAL GP III, L.P., GENERAL PARTNER OF NEW EMERGING MEDICAL OPPORTUNITIES FUND III,

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216318d1_sc13ga.htm SC 13G/A 86866
  Complete submission text file 0001104659-21-021947.txt   88502
Mailing Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7
Business Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7 514 849 8777
SECTORAL ASSET MANAGEMENT INC (Filed by) CIK: 0001274413 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8
Type: SC 13G/A

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91159 | Film No.: 21627692
SIC: 2834 Pharmaceutical Preparations